Ophthalmology

Highlighting the latest ophthalmology-related news reported across MJH Life Sciences™.

Over 20 years, 1 in 4 patients with ocular hypertension suffered visual field loss from primary open-angle glaucoma, according to a new study.

Highlighting the latest ophthalmology-related news reported across MJH Life Sciences™.

Classification criteria developed using machine learning will allow doctors to conduct disease-specific research about this collection of inflammatory eye diseases.

Highlighting the latest ophthalmology-related news reported across MJH Life Sciences™.

Patients with glaucoma who were tested under a quantum dot LED were able to better distinguish differences in color, indicating that the quality of light systems may have an impact on color discrimination.

Highlighting the latest ophthalmology-related news reported across MJH Life Sciences™.

A reported association between sex and mild ABCA4 alleles among patients with Stargardt disease did not hold up upon reevaluation.

Optogenics was used to partially restore a blind man’s eyesight; the FDA could soon approve Moderna’s COVID-19 vaccine for use among adolescents; HHS calls for a new investigation into COVID-19’s origins.

Highlighting the latest ophthalmology-related news reported across MJH Life Sciences™.

The technique uses optical coherence tomography angiography to assess the motion of blood flow, instead of static images.

Highlighting the latest ophthalmology-related news reported across MJH Life Sciences™.

Intravitreal dexamethasone implants stabilized, but did not improve, vision for most patients with macular edema due to retinal vein occlusion (RVO).

Blacks and Hispanics were underrepresented in relation to their US racial distribution in clinical trials for ophthalmology drug approvals from 2000 to 2020.

According to a recent review, intravitreal anti-vascular endothelial growth (anti-VEGF) drugs were not associated with an increase in major cardiovascular events.

Optical coherence tomography (OCT) appears to be less stressful to preterm infants than ocular indirect ophthalmoscopy (BIO) in assessing retinopathy of prematurity (ROP).

A study of newborns exposed to SARS-CoV-2, the virus that causes COVID-19, during gestation found few instances of ocular abnormalities, with none detected in exposed infants who testing positive.

Higher oxygen saturation targets are linked with greater progression in some cases of retinopathy of prematurity (ROP), but the incidence remains stable.

Polymerase chain reaction testing of suspected cases of adenoviral conjunctivitis in a hospital setting resulted in large cost savings by avoiding unnecessary employee furloughs.

More information will come from 4-year results, which will be critical to assess whether there is any long-term benefit to visual acuity using aflibercept.

Using a support vector machine model, researchers were able to distinguish between eyes with pathologic myopia and healthy myopia.

Researchers developed regression formulas that may be clinically beneficial for estimating visual prognosis after astigmatic correction and determining the surgical indication of astigmatic correction.

Study findings presented at ENDO 2021, the Endocrine Society's annual meeting, show rates of hearing loss among 28 patients who took teprotumumab were higher than previously reported in phase 2 and 3 trials.

Disc neovascularization (NVD) was less frequent among patients with proliferative diabetic retinopathy but was associated with more resistance to currently available treatments compared with neovascularization elsewhere (NVE), according to post hoc analysis findings published in JAMA Ophthalmology.

Fear of exposure to COVID-19 is associated with patients missing ophthalmic care appointments, suggesting the potential importance of conveying practices’ infection-control measures, according to results of a non-validated survey.